Device Week, Feb. 22, 2019 – The Latest On Lab Reimbursement And Possible LDT Regulatory Reform

Citeline Podcasts

English - February 22, 2019 22:19 - 10 minutes - 19.7 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Medtech Pressure Points And Opportunities In 2019 – The Global View From ZS

Next Episode: Device Week, Feb. 28,2019–BreastCancerImaging,TrialsPresentedAtAmericanCollegeofCardiologyConference

In this week’s podcast, senior reporter Sue Darcey talks about troubling developments for US laboratories and diagnostic test-makers that say the Government Accountability Office was mistaken in conclusions it reached in a recent report about how much labs will be billing Medicare for clinical tests. Also discussed are comments lab associations sent to US legislators, who have been trying to win industry and stakeholder consensus on a regulatory reform proposal for laboratory developed tests (LDTs) that they call the VALID Act.
Medtech Insight articles addressing topics discussed in this episode:
• Lab Groups Disagree With GAO That Medicare Will Be Overbilled For PAMA Test Payments
https://medtech.pharmaintelligence.informa.com/MT124672/Lab-Groups-Disagree-With-GAO-That-Medicare-Will-Be-Overbilled-For-PAMA-Test-Payments